Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group

AKSOYLAR, SERAP; VARAN, ALİ; Vergin, Canan; Hazar, Volkan; Akici, Ferhan; Dagdemir, Ayhan; Buyukavci, Mustafa; Kebudi, Rejin; Kurucu, Nilgun; SEVİNİR, BETÜL; ÜNAL, EMEL; Vural, Sema; Guler, Elif; APAK, Hilmi; Oniz, Haldun; KARADENİZ, CEYDA; Canpolat, Cengiz; Anak, Sema; Ilhan, Inci; İNCE, DİLEK; Cecen, REFİK; Olgun, HATİCE

doi:10.4103/0973-1482.183205

Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group

Copy For Citation

AKSOYLAR S., VARAN A., Vergin C., Hazar V., Akici F., Dagdemir A., ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.13, no.2, pp.284-290, 2017 (SCI-Expanded)

Publication Type: Article / Article
Volume: 13 Issue: 2
Publication Date: 2017
Doi Number: 10.4103/0973-1482.183205
Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
Page Numbers: pp.284-290
Keywords: Autologous stem cell rescue, high-risk neuroblastoma, treatment, Turkey, STEM-CELL RESCUE, BONE-MARROW-TRANSPLANTATION, MYELOABLATIVE THERAPY, RANDOMIZED-TRIAL, CHEMOTHERAPY, MEGATHERAPY, CLASSIFICATION, EXPERIENCE, CHILDREN, TUMORS
Dokuz Eylül University Affiliated: Yes

Abstract

Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patients by high-dose chemotherapy and stem cell rescue with intensive multimodal therapy.